Intra-Cellular Therapies (ITCI) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

ITCI is expected to report earnings to rise 10.13% to -17 cents per share on November 05

Intra-Cellular Therapies ITCI Stock Earnings Reports

Q3'24

Est.

$-0.18

Q2'24

Beat

by $0.03

Q1'24

Beat

by $0.16

Q4'23

Beat

by $0.15

Q3'23

Beat

by $0.31

The last earnings report on August 07 showed earnings per share of -15 cents, beating the estimate of -18 cents. With 385.52K shares outstanding, the current market capitalization sits at 6.70B.

View a ticker or compare two or three

Compare

ITCI

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For ITCI
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for ITCI (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a biopharmaceutical company

Industry PharmaceuticalsOther

Profile

Fundamentals

Details

Industry

Biotechnology

Address

430 East 29th Street

Phone

+1 646 440-9333

Employees

610

Web

https://www.intracellulartherapies.com